Results 141 to 150 of about 8,244 (227)

CV2: EFFECTIVENESS AND COST-EFFECTIVENESS OF EPTIFIBATIDE IN INDIVIDUAL PATIENTS WITH ACUTE CARDIAC ISCHEMIA: THE IMPORTANCE OF RISK STRATIFICATION

, 2000
DM Kent, Robin Ruthazer, J R Beshansky, HP Selker   +3 more
openalex   +1 more source

Eptifibatide is noninferior to abciximab: implications for clinical practice [PDF]

, 2010
Alexandra King
openalex   +1 more source

Primary Percutaneous Coronary Angioplasty With and Without Eptifibatide in ST-Segment Elevation Myocardial Infarction [PDF]

, 2009
Michel R. Le May, George A. Wells, Chris Glover, Derek So, Michael Froeschl, Jean-François Marquis, Edward R. O’Brien, Michèle Turek, Allyson Thomas, Malek Kass, Sachin Jadhav, Marino Labinaz   +11 more
openalex   +1 more source

Early Percutaneous Coronary Intervention, Platelet Inhibition With Eptifibatide, and Clinical Outcomes in Patients With Acute Coronary Syndromes [PDF]

, 2000
Neal S. Kleiman, A. Michael Lincoff, Greg C. Flaker, Karen S. Pieper, Robert G. Wilcox, Lisa G. Berdan, Todd J. Lorenz, Dennis V. Cokkinos, Maarten L. Simoons, Eric Boersma, Eric J. Topol, Robert M. Califf, Robert A. Harrington   +12 more
openalex   +1 more source

Successful Treatment of a Left Main Thrombus by Intracoronary Eptifibatide Infusion in a 36-Year-Old Patient

Journal of Tehran University Heart Center, 2016
The acute coronary syndrome due to the left main coronary artery (LMCA) thrombosis is a clinically rare and catastrophic event.  We describe a young man (smoker, alcoholic, and drug abuser) with a history of recent surgery and typical chest pain who had ...
Saeed Alipour-Parsa, Elham Farahani
doaj  

Tolerability and feasibility of eptifibatide in acute coronary syndrome in patients at high risk for cardiovascular disease: A retrospective analysis

, 2005
Zaher S. Azzam, Elias Sa'ad, Amal Jab Jabareen, Oron Eilam, Petru Bartha, Salim Hadad, Norberto Krivoy   +6 more
openalex   +2 more sources

Pharmacodynamics and Pharmacokinetics of Higher-Dose, Double-Bolus Eptifibatide in Percutaneous Coronary Intervention [PDF]

, 2001
Ian C. Gilchrist, J.Conor O’Shea, Teddy Kosoglou, Lisa K. Jennings, Todd J. Lorenz, Michael M. Kitt, Neal S. Kleiman, David Talley, Frank Aguirre, Charles J. Davidson, John Paul Runyon, James E. Tcheng   +11 more
openalex   +1 more source

Emergency endovascular treatment of stroke due to cervical artery dissection - impact of periprocedural GP IIb/IIIa inhibitor use on clinical outcome. [PDF]

CVIR Endovasc
Sornalingam A, Wegener S, Stattmann M, Baumann J, Thurner P, Madjidyar J, Husain HS, Krepuska M, Globas C, Luft AR, Kulcsar Z, Schubert T.   +11 more
europepmc   +1 more source

The comparative safety of abciximab versus eptifibatide in patients on dialysis undergoing percutaneous coronary intervention: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2)

, 2017
Devraj Sukul, Milan Seth, Theodore Schreiber, George Hanzel, Akshay Khandelwal, Louis Cannon, Thomas LaLonde, Hitinder S. Gurm   +7 more
openalex   +2 more sources

Correction: Latacz et al. Safety and Efficacy of Low-Dose Eptifibatide for Tandem Occlusions in Acute Ischemic Stroke. <i>Neurol. Int.</i> 2024, <i>16</i>, 253-262. [PDF]

Neurol Int
Latacz P, Popiela T, Brzegowy P, Lasocha B, Kwiecień K, Simka M.   +5 more
europepmc   +1 more source